SM
Shibibiyya Mecheri
About Shibibiyya Mecheri
Data last updated:
Shibibiyya Mecheri is a Director at Orient Drugs Private Limited (since 2022). The company operates in Pharma. Orient Drugs Private Limited reported revenue of ₹7.95 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Orient Drugs Private Limited U24231KL1997PTC011301 | Director | 04 Apr 2022 | 1997 | ₹7.95 Cr (FY 2025) | Active |
Board colleagues of Shibibiyya Mecheri
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abdu Avulan | 01827943 | Orient Drugs Private Limited | Managing Director |
| Fathima Sheikmoossa Avulan | 07460057 | Orient Drugs Private Limited | Director |
| Favas Avulan | 06759875 | Orient Drugs Private Limited | Director |
| Jameela Konndla Badiuzzaman | 07460071 | Orient Drugs Private Limited | Director |
| Mumtaz Pothaparambath | 07460080 | Orient Drugs Private Limited | Director |
| Naseer Kalappaden | 01827936 | Orient Drugs Private Limited | Director |
| Ummer Thekkepath | 07463474 | Orient Drugs Private Limited | Director |
| Zubairali Valiyathodi | 07460101 | Orient Drugs Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shibibiyya Mecheri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shibibiyya Mecheri
Shibibiyya Mecheri currently holds 1 directorship: Orient Drugs Private Limited (Director, since 04 Apr 2022, revenue ₹7.95 Cr (FY 2025)).
Shibibiyya Mecheri was first appointed on 04 Apr 2022 as Director at Orient Drugs Private Limited.
The current boards of Shibibiyya Mecheri's companies include Abdu Avulan (Orient Drugs Private Limited), Fathima Sheikmoossa Avulan (Orient Drugs Private Limited), Favas Avulan (Orient Drugs Private Limited), Jameela Konndla Badiuzzaman (Orient Drugs Private Limited), Mumtaz Pothaparambath (Orient Drugs Private Limited), Naseer Kalappaden (Orient Drugs Private Limited), among others.